SI2121691T1 - Spirociklični cikloheksanski derivati - Google Patents

Spirociklični cikloheksanski derivati

Info

Publication number: SI2121691T1
Authority: SI; Slovenia
Prior art keywords: spirocyclic cyclohexane; cyclohexane compounds; cyclohexane derivatives; spirocyclic; compounds
Prior art date: 2007-02-22

Application number

SI200830635T

Other languages

English (en)

Inventor

Stefan Schunk

Derek Saunders

Stephanie Harlfinger

Sonja Steufmehl

Original Assignee

Gruenenthal Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-02-22

Filing date

2008-02-19

Publication date

2012-06-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39531427&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2121691(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2008-02-19 Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh

2012-06-29 Publication of SI2121691T1 publication Critical patent/SI2121691T1/sl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Psychiatry (AREA)
Addiction (AREA)
Hematology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Diabetes (AREA)
Obesity (AREA)
Rheumatology (AREA)
Child & Adolescent Psychology (AREA)
Hospice & Palliative Care (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Indole Compounds (AREA)

SI200830635T 2007-02-22 2008-02-19 Spirociklični cikloheksanski derivati SI2121691T1 (sl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
DE102007009319A DE102007009319A1 (de)	2007-02-22	2007-02-22	Spirocyclische Cyclohexan-Derivate
PCT/EP2008/001271 WO2008101660A1 (de)	2007-02-22	2008-02-19	Spirocyclische cyclohexan-derivate
EP08715856A EP2121691B1 (de)	2007-02-22	2008-02-19	Spirocyclische cyclohexan-derivate

Publications (1)

Publication Number	Publication Date
SI2121691T1 true SI2121691T1 (sl)	2012-06-29

Family

ID=39531427

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200830635T SI2121691T1 (sl)	2007-02-22	2008-02-19	Spirociklični cikloheksanski derivati

Country Status (25)

Country	Link
US (1)	US7960404B2 (sl)
EP (1)	EP2121691B1 (sl)
JP (1)	JP5514556B2 (sl)
KR (1)	KR101517748B1 (sl)
CN (1)	CN101622256B (sl)
AT (1)	ATE554089T1 (sl)
AU (1)	AU2008217277B2 (sl)
BR (1)	BRPI0806794A2 (sl)
CA (1)	CA2679173C (sl)
CO (1)	CO6220948A2 (sl)
CY (1)	CY1112725T1 (sl)
DE (1)	DE102007009319A1 (sl)
DK (1)	DK2121691T3 (sl)
EC (1)	ECSP099621A (sl)
ES (1)	ES2386387T3 (sl)
HR (1)	HRP20120511T1 (sl)
IL (1)	IL200496A (sl)
MX (1)	MX2009007387A (sl)
NZ (1)	NZ578589A (sl)
PL (1)	PL2121691T3 (sl)
PT (1)	PT2121691E (sl)
RU (1)	RU2470933C2 (sl)
SI (1)	SI2121691T1 (sl)
WO (1)	WO2008101660A1 (sl)
ZA (1)	ZA200906584B (sl)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE102006033114A1 (de) *	2006-07-18	2008-01-24	Grünenthal GmbH	Spirocyclische Azaindol-Derivate
EP2240481A1 (en)	2008-01-11	2010-10-20	Albany Molecular Research, Inc.	(1-azinone) -substituted pyridoindoles as mch antagonists
RU2532545C2 (ru)	2008-03-27	2014-11-10	Грюненталь Гмбх	Замещенные производные 4-аминоциклогексана
CA2719743A1 (en)	2008-03-27	2009-10-01	Gruenenthal Gmbh	Substituted cyclohexyldiamines
US8288430B2 (en)	2008-03-27	2012-10-16	Grunenthal Gmbh	Spiro(5.5)undecane derivatives
SI2271613T1 (sl)	2008-03-27	2014-08-29	Grunenthal Gmbh	Hidroksimetilcikloheksilamini
TWI450899B (zh)	2008-03-27	2014-09-01		被取代之螺環環已烷衍生物
WO2011003005A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof
WO2011003021A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
WO2011003012A1 (en)	2009-07-01	2011-01-06	Albany Molecular Research, Inc.	Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
US8629158B2 (en)	2009-07-01	2014-01-14	Albany Molecular Research, Inc.	Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof
AR084209A1 (es)	2010-12-08	2013-05-02	Gruenenthal Gmbh	Metodo para la sintesis de derivados de aminociclohexanona sustituidos
WO2012088038A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Piperazinone-substituted tetrahydro-carboline mch-1 antagonists, methods of making, and uses thereof
WO2012088124A2 (en)	2010-12-21	2012-06-28	Albany Molecular Research, Inc.	Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof
HUE029070T2 (en) *	2011-12-12	2017-02-28	Gruenenthal Gmbh	(1R, 4R) -6'-Fluoro (N, N-Dimethyl- and N-methyl) -4-phenyl-4 ', 9'-dihydro-3'H-spiro [cyclohexane-1,1'- pyrano- [3,4, B] indole] -4-amine
ES2658193T3 (es)	2013-03-15	2018-03-08	Grünenthal GmbH	Cis-(E)-4-(3-fluorofenil)-2',3',4',9'-tetrahidro-N,N-dimetil-2'-(1-oxo-3-fenil-2-propenil)-espiro[ciclohexano-1,1'[1H]-pirido[3,4-b]indol]-4-amina cristalina
PL3169666T3 (pl)	2014-07-15	2019-03-29	Grünenthal GmbH	Podstawione pochodne azaspiro(4,5)dekanu
TW201607923A (zh)	2014-07-15	2016-03-01	歌林達有限公司	被取代之氮螺環（４．５）癸烷衍生物
US10022353B2 (en) *	2015-01-23	2018-07-17	Grünenthal GmbH	Cebranopadol for treating pain in subjects with impaired hepatic and/or impaired renal function
CN107383027A (zh) *	2017-07-24	2017-11-24	扬州大学	一种四氢螺类化合物的合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
RU2265018C2 (ru) *	2001-04-18	2005-11-27	Эро-Селтик, С.А.	Производные бензимидазола и фармацевтические композиции на их основе
DE10252667A1 (de) *	2002-11-11	2004-05-27	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE10360792A1 (de) *	2003-12-23	2005-07-28	Grünenthal GmbH	Spirocyclische Cyclohexan-Derivate
DE102005016460A1 (de) *	2005-04-11	2006-10-19	Grünenthal GmbH	Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
DE102006046745A1 (de) *	2006-09-29	2008-04-03	Grünenthal GmbH	Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz

2007
- 2007-02-22 DE DE102007009319A patent/DE102007009319A1/de not_active Withdrawn
2008
- 2008-02-19 MX MX2009007387A patent/MX2009007387A/es active IP Right Grant
- 2008-02-19 NZ NZ578589A patent/NZ578589A/en not_active IP Right Cessation
- 2008-02-19 AT AT08715856T patent/ATE554089T1/de active
- 2008-02-19 KR KR1020097019738A patent/KR101517748B1/ko not_active Expired - Fee Related
- 2008-02-19 ES ES08715856T patent/ES2386387T3/es active Active
- 2008-02-19 WO PCT/EP2008/001271 patent/WO2008101660A1/de not_active Ceased
- 2008-02-19 SI SI200830635T patent/SI2121691T1/sl unknown
- 2008-02-19 RU RU2009135070/04A patent/RU2470933C2/ru not_active IP Right Cessation
- 2008-02-19 BR BRPI0806794-5A patent/BRPI0806794A2/pt not_active IP Right Cessation
- 2008-02-19 PT PT08715856T patent/PT2121691E/pt unknown
- 2008-02-19 PL PL08715856T patent/PL2121691T3/pl unknown
- 2008-02-19 CA CA2679173A patent/CA2679173C/en not_active Expired - Fee Related
- 2008-02-19 AU AU2008217277A patent/AU2008217277B2/en not_active Ceased
- 2008-02-19 DK DK08715856.4T patent/DK2121691T3/da active
- 2008-02-19 JP JP2009550672A patent/JP5514556B2/ja not_active Expired - Fee Related
- 2008-02-19 EP EP08715856A patent/EP2121691B1/de not_active Not-in-force
- 2008-02-19 HR HRP20120511AT patent/HRP20120511T1/hr unknown
- 2008-02-19 CN CN200880006055.6A patent/CN101622256B/zh not_active Expired - Fee Related
2009
- 2009-08-19 CO CO09086728A patent/CO6220948A2/es active IP Right Grant
- 2009-08-20 IL IL200496A patent/IL200496A/en active IP Right Grant
- 2009-08-21 US US12/545,261 patent/US7960404B2/en not_active Expired - Fee Related
- 2009-09-09 EC EC2009009621A patent/ECSP099621A/es unknown
- 2009-09-21 ZA ZA200906584A patent/ZA200906584B/xx unknown
2012
- 2012-05-11 CY CY20121100445T patent/CY1112725T1/el unknown

Also Published As

Publication number	Publication date
ES2386387T3 (es)	2012-08-20
CA2679173C (en)	2015-11-24
EP2121691B1 (de)	2012-04-18
ZA200906584B (en)	2010-06-30
RU2009135070A (ru)	2011-03-27
ATE554089T1 (de)	2012-05-15
KR101517748B1 (ko)	2015-05-06
JP5514556B2 (ja)	2014-06-04
CO6220948A2 (es)	2010-11-19
US7960404B2 (en)	2011-06-14
IL200496A0 (en)	2010-04-29
US20100048553A1 (en)	2010-02-25
EP2121691A1 (de)	2009-11-25
NZ578589A (en)	2012-02-24
DK2121691T3 (da)	2012-07-02
BRPI0806794A2 (pt)	2011-09-13
ECSP099621A (es)	2009-10-30
WO2008101660A1 (de)	2008-08-28
KR20090114470A (ko)	2009-11-03
DE102007009319A1 (de)	2008-08-28
PT2121691E (pt)	2012-05-25
JP2010519265A (ja)	2010-06-03
PL2121691T3 (pl)	2012-09-28
CN101622256A (zh)	2010-01-06
RU2470933C2 (ru)	2012-12-27
IL200496A (en)	2014-02-27
CA2679173A1 (en)	2008-08-28
HK1136827A1 (en)	2010-07-09
MX2009007387A (es)	2009-07-17
CY1112725T1 (el)	2016-02-10
HRP20120511T1 (hr)	2012-07-31
AU2008217277A1 (en)	2008-08-28
AU2008217277B2 (en)	2012-09-06
CN101622256B (zh)	2015-07-22

Publication	Publication Date	Title
IL200496A0 (en)	2010-04-29	Spirocyclic cyclohexane derivatives
MY149731A (en)	2013-10-14	Compounds
MX2010009922A (es)	2010-09-28	Activadores de piridazinona glucocinasa.
PL2150530T3 (pl)	2012-03-30	Podstawione pochodne sulfonamidu
MX2011011661A (es)	2011-11-18	Compuestos 1-cianoetilheterociclilcarboxamida sustituidos 750.
TW200806300A (en)	2008-02-01	New therapeutic combinations for the treatment of depression
NZ602754A (en)	2014-05-30	Substituted 1,3-benzothiazepines useful in treating metabolic disorders
CY1108794T1 (el)	2014-04-09	Σπειροκυκλικα παραγωγα κυκλοεξανιου
PH12013500007A1 (en)	2017-05-19	Piperidine derivatives and their use for the treatment of metabolic disorders
TNSN07360A1 (en)	2008-12-31	Substituted pyrrolo-pyridines, composition containing them, method for their producing and use thereof
MX2010009022A (es)	2010-09-07	Derivados 16 alfa, 17 alfa-acetal glucocorticoesteroideos y su uso.
IN2012DN03182A (sl)	2015-09-25
IL189298A0 (en)	2008-06-05	3.5-disubstituted phenyl-piperidines as modulators of dopamine meurotransmission
PH12015500860A1 (en)	2015-06-22	2-phenyl -5- heterocyclyl -tetrahydro-2h- pyran-3-amine compounds for use in the treatment of diabetes and its associated disorders
MY156302A (en)	2016-01-29	COMPOUNDS, COMPOSITIONS AND METHODS FOR THE TREATMENT OF ß-AMYLOID DISEASES AND SYNUCLEINOPATHIES
MX2010009395A (es)	2010-09-24	Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y procesos para preparacion de los mismos.
PH12012501863A1 (en)	2021-06-23	3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
TW200722081A (en)	2007-06-16	New therapeutic combinations for the treatment or prevention of depression
MX2010009756A (es)	2010-10-15	Agonistas de receptores muscarinicos, composiciones, metodos de tratamiento de los mismos, y proceso para preparacion de los mismos.
TN2011000223A1 (en)	2012-12-17	Substituted tetrahydropyran spiro pyrrolidinone and piperidinone, preparation and therapeutic use thereof
TW200806321A (en)	2008-02-01	New therapeutic combinations for the treatment or prevention of psychotic disorders
MX2011008126A (es)	2011-08-17	Compuestos de indol sustituidos como moduladores del receptor 1 de bradiquinina.
MX2012006287A (es)	2012-07-03	Activadores de azaindol glucocinasa.
WO2009148291A3 (en)	2010-03-11	3- or 4-substituted piperidine compounds
TW200616637A (en)	2006-06-01	Novel quinoxalinone norepinephrine reuptake inhibitors for the treatment of central nervous system disorders